Efficacy of Kangfuxin liquid for preventing and treating chemotherapy-induced oral mucositis: a systematic review and meta-analysis of randomized controlled trials.

Front Pharmacol · 2025 · PMC12011798 · PMID 40264666

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

3.3.4 Efficacy rate of KFXL on severe CTOM Only two trials ( Cai, 2019 ; Liu, 2018 ) compared the efficacy rate between KFXL and BOC in the treatment of severe CTOM, and although this did not reach statistical significance, it implies that the KFXL might be more effective than the BOC.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.